二甲双胍
医学
疾病
健康衰老
糖尿病
生物信息学
药理学
老年学
内科学
生物
内分泌学
作者
Fangfang Cheng,Yanli Liu,Jang Du,Juntang Lin
出处
期刊:Aging and Disease
[Buck Institute for Research on Aging]
日期:2022-01-01
卷期号:13 (4): 970-970
被引量:26
标识
DOI:10.14336/ad.2021.1213
摘要
Aging is a major global challenge, and there is growing demand for new strategies to address the burden of aging. The intensive search for antiaging agents has led to the discovery of a variety of drugs that promote the extension of healthspan and/or life. Metformin is a safe, effective, and globally affordable antihyperglycemic agent that has gained much attention in recent years as a potential antiaging treatment. Metformin has been shown to significantly delay the onset of age-related diseases and increase lifespan in several model organisms. In this paper, we reviewed aging hallmarks and the role of metformin in countering these hallmarks. We examined the beneficial effects of metformin on several age-related diseases and the feasibility of metformin as an agent to extend lifespan and healthspan. Finally, we discussed new research directions to better understand the translational potential of metformin in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI